Trial Profile
Effect of Febuxostat on Flow Mediated Diameter in hyperuricemia patients with chronic kidney disease 5D.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 08 Aug 2015 Status changed from not yet recruiting to completed as per University Hospital Medical Information Network - Japan.
- 13 Aug 2014 New trial record